Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality-Reference-Cited by-同舟云学术

Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality

Published:2020-11 Issue:6 Volume:60 Page:e145-e152
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Stafford Emma G.^ORCID,Riviere Jim E.^ORCID,Xu Xuan,Kawakami Jessica^ORCID,Wyckoff Gerald J.^ORCID,Jaberi-Douraki Majid

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference14 articles.

1. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038];Zhou;Lancet,2020

3. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8) [published correction appears in JAMA. 2014 May 7;311(17):1809];James;JAMA,2014

4. Standards of medical care in diabetes-2020 abridged for primary care providers;Clin Diabetes,2020

5. Chapter 26: Renin and angiotensin;Hilal-Danden,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the effects of COVID-19 on patients with diabetic nephropathy: a systematic review;Annals of Medicine & Surgery;2024-04-17

2. In-silico approaches to assessing multiple high-level drug-drug and drug-disease adverse drug effects;Expert Opinion on Drug Metabolism & Toxicology;2024-02

3. A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19;Heliyon;2023-03

4. Data mining methodology for response to hypertension symptomology-application to COVID-19-related pharmacovigilance;ELIFE;2021

5. Data mining methodology for response to hypertension symptomology—application to COVID-19-related pharmacovigilance;eLife;2021-11-23